Zoetis - ZTS Stock Forecast, Price & News

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zoetis in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ZTS shares.
View ZTS analyst ratings or view top-rated stocks.

7 equities research analysts have issued 1-year target prices for Zoetis' shares. Their ZTS share price forecasts range from $180.00 to $248.00. On average, they predict the company's share price to reach $215.17 in the next twelve months. This suggests a possible upside of 43.3% from the stock's current price.
View analysts price targets for ZTS or view top-rated stocks among Wall Street analysts.

Zoetis' stock was trading at $244.03 at the beginning of the year. Since then, ZTS shares have decreased by 38.5% and is now trading at $150.10.
View the best growth stocks for 2022 here.

Zoetis saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 4,260,000 shares, an increase of 37.4% from the October 15th total of 3,100,000 shares. Based on an average trading volume of 2,010,000 shares, the days-to-cover ratio is currently 2.1 days. Approximately 0.9% of the shares of the company are short sold.
View Zoetis' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023.
View our ZTS earnings forecast.

Zoetis Inc. (NYSE:ZTS) issued its quarterly earnings data on Thursday, November, 3rd. The company reported $1.21 earnings per share for the quarter, missing the consensus estimate of $1.24 by $0.03. The company had revenue of $2 billion for the quarter, compared to analysts' expectations of $2.08 billion. Zoetis had a trailing twelve-month return on equity of 48.41% and a net margin of 25.82%. Zoetis's quarterly revenue was up .6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.25 EPS.
Read the conference call transcript.

Zoetis announced a quarterly dividend on Thursday, October 13th. Stockholders of record on Tuesday, November 1st will be given a dividend of $0.325 per share on Thursday, December 1st. This represents a $1.30 dividend on an annualized basis and a dividend yield of 0.87%. The ex-dividend date is Monday, October 31st.
Read our dividend analysis for ZTS.

Zoetis (NYSE:ZTS) pays an annual dividend of $1.30 per share and currently has a dividend yield of 0.87%. The company has been increasing its dividend for 8 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 29.68%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ZTS will have a dividend payout ratio of 24.21% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ZTS.

Zoetis updated its FY 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share guidance of $4.83-$4.90 for the period, compared to the consensus EPS estimate of $5.00. The company issued revenue guidance of $8.00 billion-$8.07 billion, compared to the consensus revenue estimate of $8.26 billion.

50 employees have rated Zoetis Chief Executive Officer Kristin Peck on Glassdoor.com. Kristin Peck has an approval rating of 82% among the company's employees. 70.0% of employees surveyed would recommend working at Zoetis to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Zoetis investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Hawkins (HWKN), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), Micron Technology (MU), Accenture (ACN) and Transocean (RIG).

Zoetis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZTS."

Zoetis' stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.84%), Vanguard Group Inc. (7.84%), State Street Corp (4.25%), Alliancebernstein L.P. (4.10%), Price T Rowe Associates Inc. MD (2.23%) and Nuveen Asset Management LLC (1.30%). Insiders that own company stock include Catherine A Knupp, Clinton A Jr Lewis, Glenn David, Gregory Norden, Heidi C Chen, Juan Ramon Alaix, Kristin C Peck, Linda Rhodes, Robert Edward Kelly, Robert W Scully, Roman Trawicki, Roxanne Lagano and Willie M Reed.
View institutional ownership trends.

Shares of ZTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ZTS stock can currently be purchased for approximately $150.10.

Zoetis (NYSE:ZTS) has a market capitalization of $69.96 billion and generates $7.78 billion in revenue each year. The company earns $2.04 billion in net income (profit) each year or $4.38 on an earnings per share basis.

The company employs 12,100 workers across the globe.

Zoetis' mailing address is 10 Sylvan Way, Parsippany NJ, 07054. The official website for the company is www.zoetis.com. The company can be reached via phone at (973) 822-7000, via email at steve.frank@zoetis.com, or via fax at 302-655-5049.